Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 12, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 12, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,15315 flagged findings
Reported transactions (Form 4)80since May 21, 2025
Corporate events (8-K)30since Aug 6, 2019
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Reverse splits in 5 years
1 reverse split in 5 years (1:12 on Jan 25, 2024) · 1:12 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 1,153)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 6, 268-K ↗Current report · Bylaws or fiscal year change
- Aug 12, 268-K ↗Current report · Results
- Aug 12, 2610-Q ↗Quarterly report
- Aug 12, 26SCHEDULE 13G/A ↗Passive stake · Adage Capital Management, L.P. · 4.0% · event on Jun 30, 26 · amendment
- Aug 7, 26SCHEDULE 13G ↗Passive stake · RA Capital Management, L.P. · 9.9% · event on Jul 31, 26
- Aug 6, 26SCHEDULE 13G/A ↗Passive stake · FMR LLC · 10.3% · event on Jun 30, 26 · amendment
- Jul 31, 26SCHEDULE 13G ↗Passive stake · Vanguard Capital Management · 5.0% · event on Jun 30, 26
- Jul 31, 268-K ↗Current report · Entered a material agreement
- Jul 30, 26424B5 ↗Securities offering
- Jul 29, 268-K ↗Current report · Results
- Jul 29, 26424B5 ↗Securities offering
- Jul 2, 26S-3 ↗Securities offering
Insider transaction · 11 Form 4 filingsshow all 11hide
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 21, 26Form 4 ↗Insider transaction
- May 20, 268-K ↗Current report · Bylaws or fiscal year change · Shareholder vote results
- May 18, 26Form 4 ↗Insider transaction
1,153 filings on record, the oldest from Jun 29, 99.
Listing the 25 most recent filings of the 1,153 on record.
78144
7 material agreements entered2024 – 2026show all 7hide
- Jul 31, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Apr 6, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jan 27, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 12, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jul 7, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Dec 16, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Aug 13, 24Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- May 28, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 17, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 2, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Aug 1, 23Restructuring plan with committed costs8-K 2.05 ↗
- May 18, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 31, 23Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Jul 19, 22Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- May 17, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 10, 22A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Oct 29, 21A material agreement was terminated8-K 1.02 ↗
- Jun 11, 21Entered a material agreement+2 more in the same filing8-K 1.01 ↗
12 older filings not shown · The record reaches back to Jan 13, 05.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jul 16, 19Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- Sep 4, 14Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
- Feb 12, 08Past accounts declared unreliable and being restated8-K 4.02 ↗
The full record holds 7 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- FMR LLC10.3%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- JANUS HENDERSON GROUP PLC10.0%Nov 28, 25SCHEDULE 13G/A ↗1 earlier filing
- RA Capital Management, L.P.9.9%Jul 31, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- HIGHBRIDGE CAPITAL MANAGEMENT LLC8.2%Mar 31, 26SCHEDULE 13G/A ↗
- Alyeska Investment Group, L.P.6.0%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 4 more holdershide
- Vanguard Capital Management5.0%Jun 30, 26SCHEDULE 13G ↗
- The Vanguard Group5.0%Dec 31, 25SCHEDULE 13G/A ↗
- Adage Capital Management, L.P.4.0%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- Deep Track Capital, LP2.4%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).
Stock compensation, tax and giftsshow the 40 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- May 20, 26Compensationamount n/aPETER KIESCFO↗
- May 20, 26Tax$6KPETER KIESCFO↗
- May 20, 26Compensationamount n/aLaurent HumeauChief Scientific Officer↗
- May 20, 26Tax$3KLaurent HumeauChief Scientific Officer↗
- May 20, 26Compensationamount n/aJacqueline Elizabeth SheaChief Executive Officer↗
- May 20, 26Tax$15KJacqueline Elizabeth SheaChief Executive Officer↗
- May 20, 26Compensationamount n/aMichael John SumnerChief Medical Officer↗
- May 20, 26Tax$3KMichael John SumnerChief Medical Officer↗
- May 15, 26Compensationamount n/aPETER KIESCFO↗
- May 15, 26Tax$3KPETER KIESCFO↗
- May 15, 26Compensationamount n/aLaurent HumeauChief Scientific Officer↗
- May 15, 26Tax$2KLaurent HumeauChief Scientific Officer↗
- May 15, 26Compensationamount n/aJacqueline Elizabeth SheaChief Executive Officer↗
- May 15, 26Tax$10KJacqueline Elizabeth SheaChief Executive Officer↗
- May 15, 26Compensationamount n/aMichael John SumnerChief Medical Officer↗
- May 15, 26Tax$884Michael John SumnerChief Medical Officer↗
- Mar 31, 26Compensationamount n/aMichael John SumnerChief Medical Officer↗
- Mar 31, 26Tax$2KMichael John SumnerChief Medical Officer↗
- Feb 26, 26Compensationamount n/aPETER KIESCFO↗
- Feb 26, 26Tax$5KPETER KIESCFO↗
- Feb 26, 26Compensationamount n/aPETER KIESCFO↗
- Feb 26, 26Tax$11KPETER KIESCFO↗
- Feb 26, 26Compensationamount n/aDavid B. Weiner↗
- Feb 26, 26Compensationamount n/aLaurent HumeauChief Scientific Officer↗
- Feb 26, 26Tax$4KLaurent HumeauChief Scientific Officer↗
- Feb 26, 26Compensationamount n/aLaurent HumeauChief Scientific Officer↗
- Feb 26, 26Tax$5KLaurent HumeauChief Scientific Officer↗
- Feb 26, 26Compensationamount n/aJacqueline Elizabeth SheaChief Executive Officer↗
- Feb 26, 26Tax$14KJacqueline Elizabeth SheaChief Executive Officer↗
- Feb 26, 26Compensationamount n/aJacqueline Elizabeth SheaChief Executive Officer↗
- Feb 26, 26Tax$24KJacqueline Elizabeth SheaChief Executive Officer↗
- Feb 26, 26Compensationamount n/aMichael John SumnerChief Medical Officer↗
- Feb 26, 26Compensationamount n/aMichael John SumnerChief Medical Officer↗
- Feb 26, 26Tax$7KMichael John SumnerChief Medical Officer↗
- Jun 30, 25Compensationamount n/aMichael John SumnerChief Medical Officer↗
- May 21, 25Compensationamount n/aDavid B. Weiner↗
- May 21, 25Compensationamount n/aROGER D DANSEY↗
- May 21, 25Compensationamount n/aWENDY L YARNO↗
- May 21, 25Compensationamount n/aSIMON X BENITO↗
- May 21, 25Compensationamount n/aJay Shepard↗
The full record holds 136 transactions and goes back to Jan 15, 23.
Its sector and its market
Inovio Pharmaceuticals, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Inovio Pharmaceuticals, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Inovio Pharmaceuticals, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,153 documents on file, from Jun 29, 1999 to Oct 6, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.